Investigating the Effect of Ursodeoxycholic acid and Phototherapy against Phototherapy alone in Reducing the Plasma Level of Bilirubin in Infants

Phase 3

Recruiting

• Conditions: Hyperbilirubinemia.; Other disorders of bilirubin metabolism; E80.6

• Registration Number: IRCT20231220060483N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. GA> 37 W
No Congenital abnormality
No Asphyxia
No congenital heart disease
No need for oxygen
Birth weight more than 2500
The age of the baby is between 2 and 14 days
No sepsis symptoms

Exclusion Criteria

Lack of parental consent
A baby admitted to the NICU
Initial serum bilirubin less than 15 g/d

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum bilirubin level at different hours. Timepoint: At the beginning of the baby's hospitalization and at 6, 24 and 36 hours after the start of treatment. Method of measurement: A blood sample is taken and the answer is announced by the laboratory.